July 26, 2010 — The US Food and Drug Administration (FDA) has approved the first generic formulation of enoxaparin sodium injection (Sandoz, Inc; brand name, Lovenox; Sanofi-Aventis US, LLC), a ...

Dec. 22, 2004 — The U.S. Food and Drug Administration (FDA) approved in October revisions to drug safety labeling to advise healthcare professionals of the following changes: use of the multidose ...

(RTTNews) - Sandoz, Inc., an unit of Novartis Pharma AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high ...

Patients exposed to a higher dose may be subject to bleeding complications. Apotex Corp announced the voluntary recall of 2 batches of Enoxaparin Sodium Injection ...

Princeton, NJ, Sandoz Inc. (“Sandoz”) is initiating a recall of one lot (SAB06761A, Exp 04/2023) of Enoxaparin Sodium Injection, USP 40 mg/0.4 mL Single-Dose Syringes to the consumer level. A portion ...

CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated generic injectables company today announced the launch of Enoxaparin Sodium Injection, USP, the generic ...

PARIS, May 18 (Reuters) - Sanofi-Aventis has won U.S. health authority clearance to use its bloodthinner Lovenox in patients who suffer from the most severe type of heart attack, the French drugmaker ...

In a significant advancement for emergency care, Jharkhand's health department is introducing life-saving enoxaparin injections in district and medical college hospitals that do not have cardiology ...

Stock in Momenta Pharmaceuticals Inc. dropped sharply Tuesday following news that Teva Pharmaceuticals Industries Ltd. received a minor deficiencies letter on its application for a generic Lovenox ...

Uninsured people who paid out of pocket for the anticoagulant drug Lovenox may be eligible for a payment from a $120 million proposed settlement in a dispute between Nashville General Hospital and two ...